The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Trientine HCl (Brand name: Syprine )
- Manufactured by
Merck Sharp & Dohme Research
FDA-approved indication: Treatment of patients with Wilson's disease who are intolerant, or inadequately responsive to penicillamine.
National Library of Medicine Drug Information Portal